Stockreport

Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]

Longboard Pharmaceuticals, Inc.  (LBPH) 
PDF Presented late-breaking data for bexicaserin from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting in April 2024 Bexicaserin global Phase 3 [Read more]